EyePoint, Inc. Proceeds from Sale of Available-for-sale Securities
EyePoint, Inc. (EYPT) reported Proceeds from Sale of Available-for-sale Securities of $1.10 million for the 12-month period ending 2012-06-30, per its 10-K filed 2014-09-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities · last filed 2014-09-11
- EyePoint, Inc. proceeds from sale of available-for-sale securities for the quarter ending 2012-06-30 was $1.00K.
- EyePoint, Inc. proceeds from sale of available-for-sale securities for the quarter ending 2012-03-31 was $0.00.
- EyePoint, Inc. proceeds from sale of available-for-sale securities for fiscal 2012 was $1.10M.
| Period end | Proceeds from Sale of Available-for-sale Securities 3 month | Proceeds from Sale of Available-for-sale Securities 6 month | Proceeds from Sale of Available-for-sale Securities 9 month | Proceeds from Sale of Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2012-06-30 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11 | $1.00K derived: sum of 2 quarters · filed 2014-09-11 | $1.10M 10-K · filed 2014-09-11 | |
| 2012-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-14 | $1.10M 10-Q · filed 2013-05-14 | ||
| 2011-12-31 | $1.10M 10-Q · filed 2013-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |